NCT04234178

Brief Summary

Labor is the process where the cervix is prepared to allow the baby to pass from the uterine cavity to the outside world. In the ordinary course, it ends with spontaneous or instrumental vaginal delivery or cesarean section. Traditionally, the first stage in which the cervix is passively dilated in response to uterine contractions consists of the second stage in which the mother passes the baby through the vagina and the third stage, the exit of the placenta. In the first stage of labor, pain is caused by uterine contractions and pressure on the cervix. Pain is transmitted through the T10-L2 spinal nerves and is felt in the abdominal wall, waist, hips, or thighs. In the second stage, pain from the vagina and perineum is added to uterine pain. This pain is transmitted by the pudendal nerves through the S2-4 nerve roots. In this study, we aimed to investigate the effects of dural puncture epidural analgesia versus combined spinal-epidural analgesia with epidural volume extension on labor variables.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 21, 2020

Completed
11 days until next milestone

Study Start

First participant enrolled

February 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2021

Completed
Last Updated

February 8, 2022

Status Verified

February 1, 2022

Enrollment Period

1 year

First QC Date

January 16, 2020

Last Update Submit

February 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • First Epidural top-up time

    Time elapsed between the end of local anesthetic injection and the return of pain \>4 on the NPRS.

    First 24 hours

Secondary Outcomes (3)

  • Sacral analgesia time

    First 24 hours

  • Performance time

    First 24 hours

  • Incidence of Side Effect

    First 24 hours

Study Arms (2)

Dural puncture epidural

ACTIVE COMPARATOR

2 µg/ml fentanyl + %0,125 bupivacaine (20 ml) to epidural

Drug: Epidural

Combined spinal-epidural with epidural volume extension

ACTIVE COMPARATOR

10 µg fentanyl + 2 mg bupivacaine to intrathecal 7.4 ml saline volume to epidural

Drug: Intrathecal+Epidural

Interventions

2 µg/ml fentanyl + %0,125 bupivacaine (20 ml) to epidural

Dural puncture epidural

10 µg fentanyl + 2 mg bupivacaine to intrathecal 7.4 ml saline volume to epidural

Combined spinal-epidural with epidural volume extension

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant patients
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA I and II parturients
  • Pregnant patients in active labor
  • active labor with cervical dilation \< 5cm
  • weeks of gestational age
  • Pregnant women between the ages of 18 and 45

You may not qualify if:

  • Patients who do not want to participate voluntarily in the study
  • Pregnant women outside the age range of 18 - 45
  • Pregnants other than Nullipar
  • Patients with allergic reactions to anesthesia and analgesia drugs to be used
  • Severe systemic disease (kidney, liver, pulmonary, endocrine, cardiac)
  • Gestational comorbidity (preeclampsia, eclampsia, diabetes mellitus, etc.)
  • Substance abuse history
  • Chronic pain history
  • Psychiatric problems and communication difficulties
  • BMI\> 35 kg / m2
  • Failure in neuraxial interventions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ataturk University

Erzurum, Yakutiye, 25100, Turkey (Türkiye)

Location

Erzurum Regional Training Research Hospital

Erzurum, Yakutiye, 25100, Turkey (Türkiye)

Location

Related Publications (3)

  • Contreras F, Morales J, Bravo D, Layera S, Jara A, Riano C, Pizarro R, De La Fuente N, Aliste J, Finlayson RJ, Tran DQ. Dural puncture epidural analgesia for labor: a randomized comparison between 25-gauge and 27-gauge pencil point spinal needles. Reg Anesth Pain Med. 2019 May 22:rapm-2019-100608. doi: 10.1136/rapm-2019-100608. Online ahead of print.

    PMID: 31118278BACKGROUND
  • Chau A, Bibbo C, Huang CC, Elterman KG, Cappiello EC, Robinson JN, Tsen LC. Dural Puncture Epidural Technique Improves Labor Analgesia Quality With Fewer Side Effects Compared With Epidural and Combined Spinal Epidural Techniques: A Randomized Clinical Trial. Anesth Analg. 2017 Feb;124(2):560-569. doi: 10.1213/ANE.0000000000001798.

    PMID: 28067707BACKGROUND
  • Doymus O, Aydin ME, Bedir Z, Tor IH, Ejder Tekgunduz S, Doymus G, Celik EC, Ahiskalioglu A. Epidural volume extension versus dural puncture epidural analgesia for labor: A prospective randomized study. Medicine (Baltimore). 2025 Mar 7;104(10):e41691. doi: 10.1097/MD.0000000000041691.

MeSH Terms

Conditions

Labor Pain

Interventions

Injections, Epidural

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Injections, SpinalInjectionsDrug Administration RoutesDrug TherapyTherapeutics

Study Officials

  • Muhammed En Aydin

    Ataturk University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 16, 2020

First Posted

January 21, 2020

Study Start

February 1, 2020

Primary Completion

February 1, 2021

Study Completion

February 7, 2021

Last Updated

February 8, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations